Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Keyword(s):
Keyword(s):
2019 ◽
Vol 95
◽
pp. 204-216
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 84
(4)
◽
pp. 743-756
◽